Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytotoxic T Cell Expression of Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) in Viral Hepatitis C-Mediated Hepatocellular Carcinoma
Reham Hammad, Reda Badr Aglan, Shaymaa A. Mohammed, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12541-12541
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients
Mona A. Eldosoky, Reham Hammad, Asmaa A. Elmadbouly, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3157-3157
Open Access | Times Cited: 55
LncRNA NNT-AS1/hsa-miR-485–5p/HSP90 axis in-silico and clinical prospect correlated-to histologic grades-based CRC stratification: A step toward ncRNA Precision
Nada M. El-Sheikh, Ahmed I. Abulsoud, Amal Fawzy, et al.
Pathology - Research and Practice (2023) Vol. 247, pp. 154570-154570
Closed Access | Times Cited: 41
Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer
Mona M. Elanany, Dina Mostafa, Nadia Μ. Hamdy
Life Sciences (2023) Vol. 330, pp. 121997-121997
Closed Access | Times Cited: 41
CCDC144NL-AS1/hsa-miR-143-3p/HMGA2 interaction: In-silico and clinically implicated in CRC progression, correlated to tumor stage and size in case-controlled study; step toward ncRNA precision
Yasmine K. Abd El Fattah, Ahmed I. Abulsoud, Sherihan G. AbdelHamid, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126739-126739
Closed Access | Times Cited: 41
Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma
Reham Hammad, Mona A. Eldosoky, Asmaa A. Elmadbouly, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 17, pp. 15349-15364
Open Access | Times Cited: 30
Hepatocellular Carcinoma: Latest Research in Pathogenesis, Detection and Treatment
Beatrice Foglia, Cristian Turato, Stefania Cannito
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12224-12224
Open Access | Times Cited: 27
Harnessing Immunotherapy for Hepatocellular Carcinoma: Principles and Emerging Promises
Hossein Miri, Payman Rahimzadeh, Mehrdad Hashemi, et al.
Pathology - Research and Practice (2025), pp. 155928-155928
Closed Access | Times Cited: 1
In silico Analysis and Comprehensive Review of Circular-RNA Regulatory Roles in Breast Diseases; a Step-Toward non-coding RNA Precision
Nadia Μ. Hamdy, Mona G. El-Sisi, Sherine M. Ibrahim, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155651-155651
Closed Access | Times Cited: 6
Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics
Daniil Sokolov, Neha Sharda, Aindrila Banerjee, et al.
Current Pharmaceutical Design (2023) Vol. 30, Iss. 1, pp. 31-47
Closed Access | Times Cited: 14
Prognostic value of the preoperative prognostic nutritional and systemic immunoinflammatory indexes in patients with colorectal cancer
Haifeng Li, Wei Sun, Shengfeng Fu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Utilization of TEP miRNAs in tumor proliferation, diagnostic evaluation, therapeutic intervention, and prognostic assessment
Yuhan Wang, Ling Jiang, Jie Wang, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
A Large‐Scale Retrospective Study of Serum Des‐Gamma‐Carboxy Prothrombin as a Diagnostic Marker of HCC: Effect of Liver Function on Specificity
Hong Bu, Weijia Luo, Wenli Tao, et al.
Journal of Clinical Laboratory Analysis (2025)
Open Access
Neutrophil-to-lymphocyte ratio-based prognostic score can predict outcomes in patients with advanced non-small cell lung cancer treated with immunotherapy plus chemotherapy
Shan Liao, Huiying Sun, Hao Lu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Decoding the role of nucleic acid binding protein 2 in lipid dysregulation and hepatocellular carcinoma progression through LKB1-mediated mitochondrial dysfunction
Chengchen Dai, Yun Tong, Nan Bai, et al.
Cellular Signalling (2025) Vol. 132, pp. 111820-111820
Closed Access
PSMA3-AS1: a promising LncRNA as a diagnostic and prognostic biomarker in human cancers
Yunxia Niu, Junqing Meng, Xue Zhao, et al.
Gene (2025), pp. 149521-149521
Closed Access
Systemic inflammation response index as a predictor of 3-month functional outcomes in acute ischemic stroke patients following intravenous thrombolysis
Xinxin Chen, Yangla Xie, Chao Yu, et al.
Neuroscience (2025)
Closed Access
A comprehensive review and in silico analysis of the role of survivin (BIRC5) in hepatocellular carcinoma hallmarks: A step toward precision
Nesrine A Mohamed, Rania Hassan Mohamed, John F. Kennedy, et al.
International Journal of Biological Macromolecules (2025), pp. 143616-143616
Closed Access
Prognostic impact of body composition in hepatocellular carcinoma patients with immunotherapy
Lilong Zhang, Xinyi Li, Kunpeng Wang, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 2
MicroRNA: Exploring Their Multifaceted Role in Cancer
Nadia Μ. Hamdy, Ahmed S. Doghish, Ahmed A. El-Husseiny, et al.
Interdisciplinary cancer research (2024)
Closed Access | Times Cited: 2
Comprehensive bioinformatics analysis of integrator complex subunits: expression patterns, immune infiltration, and prognostic signature, validated through experimental approaches in hepatocellular carcinoma
Yifei Xu, Wenlian Liao, Ting Wang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
LAIR1 promotes hepatocellular carcinoma cell metastasis and induces M2‐macrophage infiltration through activating AKT‐IKKβ‐p65 axis
Banglun Pan, Shuling Shen, Jun Zhao, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 9, pp. 1827-1841
Closed Access | Times Cited: 1
Leukemic B cells expression of CD200 and Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1, CD305) in Chronic Lymphocytic Leukemia patients in relation to Tregs Frequency
Reham Hammad, Eman Z. Kandeel, Claude Lambert, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155669-155669
Closed Access | Times Cited: 1
CircRNAs: Orchestrating Obesity, Thermogenesis, and Obesity-Associated Cancer Pathways
Nadia Μ. Hamdy, Mohamed Bakr Zaki, Sherien M. El‐Daly, et al.
Interdisciplinary cancer research (2024)
Closed Access
In silico and cheminformatics prediction with experimental validation of an adipogenesis cocktail, sorafenib with rosiglitazone for HCC dedifferentiation
Aya Anis, Ahmed M. Mostafa, Mariam Shaker Kerema, et al.
Journal of Genetic Engineering and Biotechnology (2024) Vol. 22, Iss. 4, pp. 100429-100429
Closed Access
Alkaline Phosphatase as Marker of Hepatocellular Carcinoma
Atif Hussain, Bahawal Khan, Zia Ud Din, et al.
Pakistan Journal of Health Sciences (2024), pp. 125-129
Closed Access
Page 1 - Next Page

Scroll to top